AYŞE HURİ ÖZDOĞAN
Istanbul Üniversitesi
H-index: 42
Asia-Turkey
Top articles of AYŞE HURİ ÖZDOĞAN
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
A case with febrile attacks and vasculopathy associated with ADA2 and MEFV pathogenic variants | Modern Rheumatology Case Reports | Kerem Parlar Eda Tahir Turanli Eda Nuhoglu Kantarci Aysa Hacioglu Asli Kirectepe Aydin | 2024/1/1 |
Frequency of AA amyloidosis has decreased in Behçet’s syndrome: a retrospective study with long-term follow-up and a systematic review: Amyloidosis in Behçet’s syndrome | Guzin Karatemiz Sinem Nihal Esatoglu Mert Gurcan Yesim Ozguler Sebahattin Yurdakul | 2023/1/1 | |
AB1323 THE MYSTERY OF FAMILIAL MEDITERRANEAN FEVER: IS THERE ANY FACTOR TRIGGERING THE ATTACKS? | SN Baspinar I Durucan MB Yuzbasioglu S Yenigun AY Ayla | 2022/6/1 | |
AB1470 DOES TESTING FOR SAA IS MORE BENEFICIAL THAN CRP FOR THE FOLLOW-UP OF PATIENTS WITH FMF? | Mert Oztas O Selvi B Ergezen H Ozdogan S Ugurlu | 2022/6/1 | |
AB1305 A SYSTEMATIC REVIEW OF AA AMYLOIDOSIS AMONG PATIENTS WITH BEHÇET’S SYNDROME | G Karatemiz SN Esatoglu M Gurcan Y Ozguler S Yurdakul | 2022/6/1 | |
AB1322 APPENDICITIS STILL A MISDIAGNOSIS FOR FMF PATIENTS | SN Baspinar A Alkan MB Yuzbasioglu S Yenigun AY Ayla | 2022/6/1 | |
AB1325 DIAGNOSTIC DELAY IN FAMILIAL MEDITERRANEAN FEVER: IS IT STILL A PROBLEM? | MB Yuzbasioglu AY Ayla I Besiroglu SN Baspinar S Yenigun | 2022/6/1 | |
Correction to: Late-onset familial mediterranean fever: single-center experience and literature review | Okan Aydin Bugra Han Egeli Huri Ozdogan Serdal Ugurlu | 2022/8/1 | |
POS1378 ARTHRITIS IN PATIENTS WITH FAMILY MEDITERRANEAN FEVER | S Yenigun AY Ayla SN Baspinar MB Yuzbasioglu A Alkan | 2022/6/1 | |
Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination rates | Rheumatology International | Aysa Hacioglu Sermin Borekci Melike Melikoglu Yesim Ozguler Sinem Nihal Esatoglu | 2022/8 |
Frequency and severity of COVID‐19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine | Journal of medical virology | Mert Oztas Murat Bektas Ilker Karacan Numune Aliyeva Ayten Dag | 2022/7 |
Antibody responses to inactivated and mRNA SARS-CoV-2 vaccines in familial Mediterranean fever patients treated with interleukin-1 inhibitors | Rheumatology | Serdal Ugurlu Ruveyda Akcin Ali Yagiz Ayla Bekir Kocazeybek Mert Oztas | 2022/6/1 |
POS1351 CAUSES OF HOSPITALIZATION IN BEHÇET SYNDROME | Y Ozguler G Hatemi AS Pala SN Esatoglu S Ugurlu | 2021/6/1 | |
Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience | Rheumatology | Serdal Ugurlu Bilgesu Ergezen Bugra Han Egeli Oguzhan Selvi Huri Ozdogan | 2021/5 |
Soluble TREM-1 levels in familial Mediterranean fever related AA-amyloidosis | Immunological Investigations | Serdal Ugurlu Bugra Han Egeli Ibrahim Murat Bolayirli Huri Ozdogan | 2021/2/17 |
SAT0518 CANAKINUMAB TREATMENT IN ADULT PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER: A SINGLE-CENTER STUDY | S Ugurlu BH Egeli O Selvi B Ergezen A Hadzalic | 2020/6/1 | |
Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial | Annals of the rheumatic diseases | Seza Ozen Eldad Ben-Cherit Ivan Foeldvari Gil Amarilyo Huri Ozdogan | 2020/10/1 |
AB1325-HPR THE TRANSITION FROM PEDIATRIC TO ADULT RHEUMATOLOGY OF 347 PATIENTS AT A SINGLE CENTER | S Ugurlu BH Egeli A Adrovic K Barut S Sahin | 2020/6/1 | |
The efficacy of anti-IL-1 treatment in three patients with coexisting familial Mediterranean fever and multiple sclerosis | Multiple Sclerosis and Related Disorders | Huri Ozdogan Serdal Ugurlu Ugur Uygunoglu Melih Tutuncu Ahmet Gul | 2020/10/1 |
Late-Onset Famılıal Medıterranean Fever: Sıngle-Center Experıence And Lıterature Revıew | Okan Aydin Bugra Han Egeli Huri Ozdogan Serdal Ugurlu | 2020/2/10 |